市場調査レポート
商品コード
1433457
下肢補綴の世界市場:2023-2030年Global Lower Limb Prosthetics Market 2023-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
下肢補綴の世界市場:2023-2030年 |
出版日: 2024年01月14日
発行: Orion Market Research
ページ情報: 英文 200 Pages
納期: 2~3営業日
|
世界の下肢補綴市場は予測期間(2023-2030年)にCAGR 5.2%で成長すると予測されます。下肢義肢市場の重要な寄与要因としては、強固なヘルスケアインフラ、下肢義肢の研究開発投資の増加、外傷や事故事例の増加などが挙げられます。交通事故は、脚、膝、足などの四肢を含む様々な骨の骨折につながります。英国政府提供の国家統計によると、2022年には29,742人が死亡または重傷(KSI)の死傷者、1,711人が死亡症例、135,480人が全重度の死傷者でした。その結果、英国では外科手術の件数が増加しています。
種類の中では、人工股関節サブセグメントが予測期間中に成長すると予測されます。このセグメントを牽引するのは、人口の間で関節炎の有病率が増加していることと、人工股関節手術の技術的進歩です。米国疾病管理予防センターによると、2019-2021年の間に米国成人の約5人に1人(21.2%)、約5,320万人が医師診断の関節炎を患っていました。関節炎は男性(16.3%)に比べ、女性(20.9%)に多いです。したがって、関節炎の罹患率の増加は、人工股関節の需要を促進すると予想されます。
世界の下肢補綴市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、南米)を含む地域別にさらに細分化されています。中でも北米が世界市場で大きなシェアを占めています。下肢補綴の需要の高まり、高齢者人口の増加、医療費の増加が地域市場に貢献しています
すべての地域の中で、アジア太平洋地域は予測期間中に著しいCAGRで成長すると予測されています。アジア太平洋地域では、人口増加、高齢化、重傷者の増加などの要因によって、糖尿病などの慢性疾患の有病率が上昇しています。中国がアジア太平洋地域の下肢補綴市場を独占しており、インド、日本、韓国、その他アジア太平洋地域がこれに続いています。中国の下肢補綴市場は、下肢補綴の採用が増加していること、糖尿病などの慢性疾患の有病率が増加していることから成長を遂げています。世界保健機関(WHO)によると、中国の糖尿病患者数は世界で最も多く、2019年には約1億1,600万人の有効患者がおり、2040年には1億5,000万人に増加すると予測されています。2009年の推定糖尿病有病率は3.9%で、2030年には5.4%に増加すると予測されています。中国の20~79歳の成人における糖尿病有病率は、2020~2030年の間に8.2%から9.7%に増加すると予測されています。
Global Limb Lower Prosthetics Market Size, Share & Trends Analysis Report by Technology (Electric Powered Lower Extremity Prosthetics, Conventional Lower Extremity Prosthetics, and Hybrid Lower Extremity Prosthetics), by Type (Prosthetics Leg, Prosthetics Foot, Prosthetics Knee, Prosthetics Hip, and Prosthetics Ankle), by End-Use (Hospitals, Clinics, and Others), Forecast Period (2023-2030)
The global lower limb prosthetics market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). Significant factors contributing to the limb lower prosthetics market include robust healthcare infrastructure, increasing investment in R&D of the limb lower prosthetics, and increasing number of trauma and accident cases. Road accidents lead to fractures of various bones, including those in the extremities such as the legs, knee, and foot. According to the national statistics provided by the UK government, in 2022, 29,742 people were killed or seriously injured (KSI) casualties, 1,711 fatalities cases were registered and 135,480 were casualties of all severities. As a result, the number of surgical procedures is increasing in the UK.
The global lower limb prosthetics market is segmented on the by technology, type, and end-use. Based on the technology, the market is sub-segmented into electric powered lower extremity prosthetics, conventional lower extremity prosthetics, and hybrid lower extremity prosthetics. Based on the type, the market is sub-segmented into prosthetics leg, prosthetics foot, prosthetics knee, prosthetics hip, and prosthetics ankle. Further, based on the end-use, the market is sub-segmented into hospitals, clinics, and others. Others includes Research Institute. Among the end-use, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the affordability, accessibility, and improved function.
Among the types, prosthetics hip sub-segments expected to grow over the forecast period. The segment is driven by the increasing prevalence of arthritis among the population and technological advancements in prosthetic hip surgeries. According to the Centers for Disease Control and Prevention, during 2019-2021, about 1 in 5 US adults (21.2%) or about 53.2 million people had doctor-diagnosed arthritis. Arthritis was more common among women (20.9%) compared to men (16.3%). Thus, the increasing incidence of arthritis is expected to drive the demand for prosthetics hip.
The global lower limb prosthetics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America held considerable share in the global market. The growing demand for lower limb prosthetics, increasing geriatric population, and rising healthcare expenditure contributing to the regional market.
Among all regions, the Asia-Pacific region is anticipated to grow at a significant CAGR over the forecast period. The Asia-Pacific region is experiencing a rise in the prevalence of chronic diseases such as diabetes, driven by factors such as population growth, aging demographics, and the growing numbers of severe injuries. China dominates the Asia-Pacific lower limb prosthetics market followed by India, Japan, South Korea, and the rest of the Asia-Pacific economies. The lower limb prosthetics market in China is experiencing growth owing to the increasing adoption of lower limb prosthetics and increasing prevalence of chronic disorders, such as diabetes. According to the World Health Organization, China has the highest number of diabetic patients globally, with nearly 116 million active cases in 2019, and is expected to increase to 150 million by 2040. The estimated diabetes prevalence rate in China in 2009 was 3.9% and is projected to increase to 5.4% by 2030. The prevalence of diabetes in Chinese adults aged 20-79 years is projected to increase from 8.2% to 9.7% during 2020-2030.
The major companies serving the lower limb prosthetics market include Blatchford Inc., Bauerfeind AG, Otto Bock HealthCare LP, WillowWood Global LLC., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2021, Boston Orthotics & Prosthetics partnered with the Central Ohio Orthotic & Prosthetic Center (COOP) to provide pediatric orthotic and prosthetic services for patients and families in Central Ohio, including those of Nationwide Children's Hospital.